Cleared Traditional

K220171 - NES Reprocessed 0.9mm Turbo Elite Laser Atherectomy Catheter (FDA 510(k) Clearance)

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2022
Decision
161d
Days
Class 2
Risk

K220171 is an FDA 510(k) clearance for the NES Reprocessed 0.9mm Turbo Elite Laser Atherectomy Catheter. Classified as Reprocessed Atherectomy Catheter (product code QTF), Class II - Special Controls.

Submitted by Northeast Scientific, Inc. (Waterbury, US). The FDA issued a Cleared decision on July 1, 2022 after a review of 161 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4875 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Northeast Scientific, Inc. devices

Submission Details

510(k) Number K220171 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 21, 2022
Decision Date July 01, 2022
Days to Decision 161 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
36d slower than avg
Panel avg: 125d · This submission: 161d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code QTF Reprocessed Atherectomy Catheter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4875
Definition Reprocessed Atherectomy Device For Peripheral Vasculature. Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.